Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PAK1 inhibitors(PAK protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18N2O |
InChIKeyBAIIKMBZYOWCBK-UHFFFAOYSA-N |
CAS Registry445007-59-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Cancer | Preclinical | CN | 27 Mar 2019 |